itinai content

  • AI News
  • AI Sales
  • Apple AI
  • Biohacking
  • Clinical Trials
  • Compare
  • Computer Vision
  • DeepSense
  • farma
  • Instruments
  • Management
  • Marketing
  • Marktechpost
  • Open AI
  • resume
  • КП
  • Baseline serum metabolites predict fractures in individuals who were Black and had type 2 diabetes

    18 июня, 2026

    CONCLUSION: In summary, the metabolic differences identified here highlight the role of altered systemic metabolism and its relationship to fracture risk. Future investigations will determine if the identified metabolites serve as predictors of fracture in patients with T2D who are not Black. →

    Clinical Trials
  • Best lead scoring automation tools for sales & marketing teams: Our 2026 picks

    18 июня, 2026

    Sales teams today aren’t struggling with a lack of leads—they’re struggling with knowing which leads actually matter. Between disconnected tools, manual qualification processes, and subjective scoring, most teams often end up prioritizing the wrong prospects, slowing down sales cycles. According to HubSpot, 28% of sales professionals cite lengthy sales processes as the primary reason good… →

    AI Sales
    AI, Analytics, B2BMarketing, B2BSales, BrandStrategy, ContentMarketing, ConversionOptimization, CustomerExperience, DataDriven, DigitalMarketing, Ecommerce, GrowthHacking, InboundMarketing, LeadGeneration, MarketingAutomation, MarketingTips, Salesforce, SEO, SocialSelling, TechnologyTrends
  • Phase Ib, multicentre, open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneously administered mosunetuzumab in participants with systemic lupus erythematosus

    18 июня, 2026

    CONCLUSIONS: Mosunetuzumab demonstrated dose-dependent peripheral B-cell depletion and a safety profile consistent with prior studies in follicular lymphoma. Based on these data, mosunetuzumab is currently being evaluated in a phase II study in severe SLE (NCT07598396). →

    Clinical Trials
  • Trauma-focused therapy integrated with cognitive behavioural therapy for psychosis for people with post-traumatic stress disorder and psychosis (the STAR trial): a multicentre, pragmatic, randomised trial in the UK

    18 июня, 2026

    BACKGROUND: People with psychosis have high rates of post-traumatic stress disorder (PTSD), which is associated with a poor prognosis. We aimed to investigate the effectiveness of a trauma-focused therapy integrated with cognitive behavioural therapy for psychosis (CBTp) in people with psychosis. →

    Clinical Trials
  • Safety and efficacy of levacetylleucine in ataxia-telangiectasia: a phase 3, randomised, double-blind, placebo-controlled crossover trial

    18 июня, 2026

    BACKGROUND: Ataxia-telangiectasia is a rare, autosomal recessive neurodegenerative disorder. Levacetylleucine (N-acetyl-L-leucine) has been shown to be efficacious for the treatment of neurological manifestations and to have a disease-modifying effect in lysosomal storage disorders such as Niemann-Pick disease type C. We aimed to assess the safety and efficacy of levacetylleucine for paediatric and adult patients with… →

    Clinical Trials
  • Early vs Late Initiation of Extracorporeal Membrane Oxygenation: Protocol for a Prospective, Randomized, Multicenter Study

    18 июня, 2026

    CONCLUSIONS: The ELIEO trial will provide robust evidence regarding the optimal timing of vvECMO initiation in patients with severe ARDS. The findings may influence clinical decision-making, resource allocation, and organizational strategies for the management of ARDS in specialized intensive care settings. →

    Clinical Trials
  • Phase II Study of Adavosertib in Patients With Tumors Containing BRCA1 and BRCA2 Mutations: Results From the NCI-MATCH ECOG-ACRIN Cancer Research Group (EAY131) Subprotocol Z1I

    18 июня, 2026

    CONCLUSION: In heavily pretreated, advanced solid tumor patients with PV in BRCA1/2, adavosertib treatment resulted in low ORR, and this trial did not meet the primary end point. →

    Clinical Trials
  • Integrating Metronomic Therapy With Standard Chemotherapy in Advanced Unresectable Head and Neck Cancer: A Randomized Trial Addressing Global Cancer Care Equity (METRO PLUS)

    18 июня, 2026

    CONCLUSION: In platinum-sensitive advanced HNSCC, the addition of triple OMCT to PC significantly improved OS and PFS with acceptable toxicity. PC + OMCT represents a feasible and cost-conscious first-line option in resource-constrained settings. →

    Clinical Trials
  • Identifying MicroRNA Biomarkers in Idiopathic Intracranial Hypertension: A Pilot Study

    18 июня, 2026

    BACKGROUND AND OBJECTIVES: Idiopathic intracranial hypertension (IIH) is characterized by raised intracranial pressure (ICP). It predominantly affects women with obesity and can cause disabling headaches and permanent visual loss. IIH is misdiagnosed in up to 40% of cases. Diagnosis and monitoring often rely on frequent invasive lumbar puncture. This pilot study aimed to identify serum… →

    Clinical Trials
  • A randomized controlled trial of N-acetylcysteine in the treatment of early-onset preeclampsia: Study Protocol

    18 июня, 2026

    BACKGROUND: Despite significant advancements in obstetric care, the incidence of preeclampsia remains a substantial public health challenge, and effective strategies to prevent the disease progression remain limited, particularly in low-resource settings. N-acetylcysteine (NAC), an antioxidant and glutathione precursor, has demonstrated anti-inflammatory and vasodilatory effects, making it a promising candidate for repurposing. However, robust evidence from… →

    Clinical Trials
1 2 3 … 978
Следующая страница